Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate

Intern Med. 2019 Sep 1;58(17):2501-2505. doi: 10.2169/internalmedicine.2740-19. Epub 2019 May 22.

Abstract

We herein report the first case of immune-mediated drug-induced liver injury that may have been caused by laninamivir. A 15-year-old girl was diagnosed with influenza and prescribed 40 mg laninamivir. Six weeks later, she was admitted to our hospital because of jaundice and fatigue. Laboratory examinations revealed elevated levels of hepatobiliary enzymes, and acute liver injury was suspected. Laboratory examinations and histological findings were characteristic of autoimmune hepatitis. Steroid treatment was ineffective, and azathioprine was added to the treatment. Twenty-two months after the onset, a second biopsy revealed the absence of inflammatory infiltrations, and the drugs were withdrawn. Liver function tests remained normal nine months after withdrawal.

Keywords: autoimmune hepatitis; drug-induced autoimmune hepatitis; drug-induced liver injury; immune-mediated drug-induced liver injury; laninamivir.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antiviral Agents / adverse effects*
  • Azathioprine / therapeutic use
  • Chemical and Drug Induced Liver Injury / etiology*
  • Female
  • Guanidines
  • Hepatitis, Autoimmune / drug therapy
  • Hepatitis, Autoimmune / etiology
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Influenza A virus
  • Influenza, Human / drug therapy*
  • Jaundice / chemically induced
  • Pyrans
  • Sialic Acids
  • Zanamivir / adverse effects
  • Zanamivir / analogs & derivatives*

Substances

  • Antiviral Agents
  • Guanidines
  • Immunosuppressive Agents
  • Pyrans
  • Sialic Acids
  • laninamivir
  • Zanamivir
  • Azathioprine